KROSKeros Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Keros Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KROSEsta | $213M#7 | — | 0.8x#1 | 0.9x#2 | 6775.0%#1 | 146.4%#2 | 27.7%#1 | 33.2%#1 | — | — | -31.9%#4 | — |
| RNAC | $245M#2 | — | — | 612.3x#6 | -99.0%#6 | -68.3%#10 | -35851.3%#6 | — | — | — | — | — |
| NATR | $230M#3 | 13.1x#1 | 1.7x#5 | 0.5x#1 | 5.7%#4 | 153.7%#1 | 5.2%#3 | 14.3%#2 | — | 9#1 | -22.6%#3 | — |
| GLSI | $229M#4 | — | 73.6x#9 | — | — | -11.2%#6 | — | -621.1%#9 | — | — | — | — |
| SIGA | $224M#5 | — | 1.4x#4 | 2.4x#3 | -31.8%#5 | -60.7%#9 | 25.1%#2 | 14.1%#3 | — | — | -57.1%#7 | 19.2%#1 |
| ELDN | $218M#6 | — | 6.6x#8 | — | — | -26.1%#7 | — | -138.2%#8 | — | — | — | — |
| BRVE | $2.6B#1 | — | — | — | — | — | — | — | — | — | — | — |
| NKTX | $206M#9 | — | 0.8x#2 | — | — | 4.3%#5 | — | -42.0%#4 | — | — | 47.9%#2 | — |
| KRRO | $204M#10 | — | 2.0x#6 | 31.9x#5 | 181.5%#2 | -40.3%#8 | -1906.4%#5 | -113.6%#7 | -155.2%#1 | — | -55.7%#6 | — |
| TNXP | $207M#8 | — | 0.9x#3 | 15.8x#4 | 29.8%#3 | 4.6%#4 | -959.1%#4 | -55.8%#6 | -234.8%#2 | — | -55.5%#5 | — |
| ANTX | $202M#11 | — | 2.7x#7 | — | — | 31.5%#3 | — | -46.3%#5 | — | — | 316.0%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice